What Some Federal Money Buys

Amazing investigations into the life sciences abound under the sponsorship of the Defense Advanced Research Projects Agency (DARPA) in the U.S. Department of Defense. Under program director Alan Rudolph, more than 25 projects around the nation and overseas will receive a total through 2004 of about $84 million. Launched in 1998, the research efforts are divided into three broad categories: Controlled Biological Systems that deal directly with living organisms; Tissue-Based Biosensors that are b

Written bySteve Bunk
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Amazing investigations into the life sciences abound under the sponsorship of the Defense Advanced Research Projects Agency (DARPA) in the U.S. Department of Defense. Under program director Alan Rudolph, more than 25 projects around the nation and overseas will receive a total through 2004 of about $84 million.

Launched in 1998, the research efforts are divided into three broad categories: Controlled Biological Systems that deal directly with living organisms; Tissue-Based Biosensors that are biological-artificial hybrids; and Biomimetics that reverse-engineer the mechanics of organisms into devices. Successful innovations will be applied to help cope with various threats of chemical and biological warfare, but much of the work derives from previous research aimed at eventual biomedical uses. Following are reports on six of the projects, selected on the basis of their appeal to readers of The Scientist.

The fit between medical and defense research is seamless for Massachusetts Institute of Technology ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies